In addition to the methods already mentioned above, the detection and quantification of EGFR mutations in plasma-cfDNA and CTCs of NSCLC patients are feasible thanks to digital PCR (dPCR) technology. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.